1.0428 - 1.1
0.91 - 5.3
Join Discuss about PRPO with like-minded investors
too many shorts stuck in PRPO anticipating offering?
71 Replies 15 👍 15 🔥
Next Dividend Date
Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care.
CEO: Paul Kinnon
HQ: 12325 Emmet St Omaha, 68164-4243 Nebraska